EzriCare Artificial Tears have been recalled due to possible contamination with Pseudomonas aeruginosa bacteria.
This bacteria can cause severe eye infections which can lead to loss of eyesight, necessitate the removal of eyeballs, and even cause death.
Call us today, or text us from this page, for a free case review if you or a loved one developed a Pseudomonas aeruginosa infection after the use of EzriCare Artificial Tears. We won’t charge you a fee until and unless we win your case.
2023 EzriCare Artificial Tears Lawsuit Latest News
May 2023
A lawsuit filed in the Central District of California, Southern Division claims a California man developed a severe infection as well as permanent damage to his vision after using EzriCare Artificial Tears.
April 2023
The FDA releases an inspection report regarding an inspection of a Global Pharma Healthcare plant located in India. The inspectors found numerous issues at the plant, including an unvalidated sterilization process, deficiencies in the aseptic cleanroom processing areas of the plant, test methods which haven’t been adequately verified, inappropriately designed equipment, a lack of written procedures for maintenance and cleaning of equipment, and insufficient quality control measures.
March 2023
A medical journal case report describes a corneal ulcer associated with EzriCare Artificial Tears.
Another medical journal case report describes keratitis associated with EzriCare Artificial Tears.
February 2023
Global Pharma Healthcare recalls EzriCare Artificial Tears due to potential Pseudomonas aeruginosa contamination.
A class action lawsuit is filed over the bacterial contamination against EzriCare LLC, Delsam Pharma LLC, EzriRx LLC, Aru Pharma Inc., and Global Pharma Healthcare Private Ltd.
A separate class action lawsuit is filed over the contamination against EzriCare LLC and Delsam Pharma LLC.
An individual lawsuit is filed over the bacterial contamination against EzriCare LLC, Wal-Mart Stores East LP, Walmart, Inc., Aru Pharma Inc. and EzriRx LLC. Global Pharma had been “red-listed” by the FDA prior to the recall of the eyedrops, and this means more future lawsuits may name retailers such as Walmart as defendants.
The AP reports that an outbreak of eye infections in a Connecticut nursing home helped officials discover the possible contamination of EzriCare Artificial Tears.
